{{Rsnum
|rsid=742105
|Gene=DTNBP1
|Chromosome=6
|position=15572843
|Orientation=plus
|GMAF=0.4963
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=DTNBP1
}}{{PMID Auto
|PMID=19077176
|Title=Variation in the dysbindin gene and normal cognitive function in three independent population samples
}}

{{PMID|19369910|OA=1
}} may be associated with [[clozapine]] response in treatment-resistant schizophrenic patients

{{PharmGKB
|RSID=rs742105
|Name_s=
|Gene_s=DTNBP1
|Feature=
|Evidence=PubMed ID:19369910
|Annotation=Patients with diplotype ACCCTC/GTTGCC, genotypes T/T+T/C, or allele T of marker rs742105 showed a better response to clozapine (0.005</=P</=0.049) in a study of patients with refractory schizophrenia.
|Drugs=clozapine
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Curated
|PharmGKB Accession ID=PA164727954
}}

{{PMID Auto
|PMID=12098102
|Title=Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.
|OA=1
}}

{{PMID Auto
|PMID=17033966
|Title=Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs742105
|overall_frequency_n=45
|overall_frequency_d=128
|overall_frequency=0.351562
|n_genomes=33
|n_genomes_annotated=0
|n_haplomes=41
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}